Malta - English - Medicines Authority

ipca produtos farmaceuticos unipessoal lda rua jose nogueira vaz no 8b 2625-099 povoa de santa iria , portugal - hydroxychloroquine sulfate - film-coated tablet - hydroxychloroquine sulfate 200 mg - antiprotozoals

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet, film coated - excipient ingredients: maize starch; calcium hydrogen phosphate dihydrate; macrogol 400; carnauba wax; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - hydroxychloroquine sulfate - film-coated tablet - 200 milligram(s) - hydroxychloroquine

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hydroxychloroquine sulfate 200mg - film coated tablet - 200 mg - active: hydroxychloroquine sulfate 200mg excipient: calcium hydrogen phosphate dihydrate carnauba wax ready to use white colorant (corresponding generic name to opadry® ys-1-7443) macrogol 400 magnesium stearate maize starch - acute and chronic rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.

Canada - English - Health Canada

jamp pharma corporation - hydroxychloroquine sulfate - tablet - 200mg - hydroxychloroquine sulfate 200mg - antimalarials

New Zealand - English - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - hydroxychloroquine sulfate 200mg - coated tablet - 200 mg - active: hydroxychloroquine sulfate 200mg excipient: calcium hydrogen phosphate colloidal silicon dioxide hypromellose magnesium stearate opadry white 85f18422 polysorbate 80 pregelatinised maize starch - acute and chronic rheumatoid arthritis

Canada - English - Health Canada

accord healthcare inc - hydroxychloroquine sulfate - tablet - 200mg - hydroxychloroquine sulfate 200mg - antimalarials

United States - English - NLM (National Library of Medicine)

west-ward pharmaceutical corp - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate tablets are indicated for the suppressive treatment and treatments of acute attacks of malaria due to plasmodium vivax , p. malariae , p. ovale , and susceptible strains of p. falciparum . it is also indicated for the treatment of discoid and systemic lupus erythematosus, and rheumatoid arthritis. use of this drug is contraindicated (1) in the presence of retinal or visual field changes attributable to any 4-aminoquinoline compound, (2) in patients with known hypersensitivity to 4-aminoquinoline compounds, and (3) for long-term therapy in children.

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate tablets are indicated for the suppressive treatment and treatment of acute attacks of malaria due to plasmodium vivax , p. malariae , p. ovale , and susceptible strains of p. falciparum . hydroxychloroquine sulfate tablets are also indicated for the treatment of discoid and systemic lupus erythematosus, and rheumatoid arthritis. use of this drug is contraindicated (1) in the presence of retinal or visual field changes attributable to any 4-aminoquinoline compound, (2) in patients with known hypersensitivity to 4-aminoquinoline compounds, and (3) for long-term therapy in children.

United States - English - NLM (National Library of Medicine)

cardinal health - hydroxychloroquine sulfate (unii: 8q2869cnvh) (hydroxychloroquine - unii:4qwg6n8qkh) - hydroxychloroquine sulfate 200 mg